Product Information

TOPIRAMATE ER 150 MG SPRINK CAP is a generic product labeled by Vitruvias Therapeutics Inc., priced at $7.0319 per EA under NDC 69680018030. Its NADAC has been published 71 times since Jul 9, 2025.

FDA first approved this application on Nov 5, 2024. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE ER 150 MG SPRINK CAP

Topiramate
$7.0319per EA

Strength

150 mg/1

NDC

69680018030

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215638

FDA Approved

11/5/2024

TE Code

AB2

On Market Since

4/7/2025

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 150 MG SPRINK CAP has been published 71 times since Jul 9, 2025, and over the history we have for it it has declined 43.6%. The table below summarizes its recorded NADAC range and movement.

Current price$7.0319 per EA
All-time high$12.4622 (Jul 16, 2025)
All-time low$7.0319 (Oct 21, 2026)
52-week high$11.1680
52-week low$7.0319
Median price$10.9012
Average price$10.2360
Largest weekly change-13.2% (Jun 17, 2026)
Weeks tracked71
Tracking sinceJul 9, 2025

Price History

1W

0.0%

1M

-4.4%

3M

-11.4%

6M

-30.9%

1Y

-39.8%

3Y

N/A

5Y

N/A

All

-43.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 150 MG SPRINK CAP?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 150 MG SPRINK CAP, manufactured by Vitruvias Therapeutics Inc., is $7.0319 per EA (NDC 69680018030), effective Nov 11, 2026.

How has the price of TOPIRAMATE ER 150 MG SPRINK CAP changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 150 MG SPRINK CAP has declined 43.6%. It has been tracked across 71 weekly CMS publications since Jul 9, 2025.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 150 MG SPRINK CAP?

Since Jul 9, 2025, the NADAC for TOPIRAMATE ER 150 MG SPRINK CAP has ranged from a low of $7.0319 (Oct 21, 2026) to a high of $12.4622 (Jul 16, 2025), with a median of $10.9012 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 150 MG SPRINK CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE ER 150 MG SPRINK CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures TOPIRAMATE ER 150 MG SPRINK CAP?

TOPIRAMATE ER 150 MG SPRINK CAP (NDC 69680018030) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.